These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 22845857)

  • 1. Efficacy of factor IX Grifols(®) in surgery: experience of an international multicentre retrospective study.
    Pérez-Garrido R; Alonso N; Jiménez-Yuste V; Haya S; Zúñiga P; Baques A; Candela M; Dávoli M; Rescia V
    Haemophilia; 2012 Sep; 18(5):e372-3. PubMed ID: 22845857
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgery in haemophilic patients with inhibitors.
    Rodriguez-Merchan EC
    Haemophilia; 2004 Sep; 10 Suppl 2():1-2. PubMed ID: 15385039
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic study of a high-purity factor IX concentrate (Factor IX Grifols) with a 6-month follow up in previously treated patients with severe haemophilia B.
    Aznar JA; Cabrera N; Matysiak M; Zawilska K; Gercheva L; Antonov A; Montañés M; Páez AM; Lissitchkov T
    Haemophilia; 2009 Nov; 15(6):1243-8. PubMed ID: 19659601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of donated clotting factors for surgeries on haemophilic patients in a resource-constrained country: a kind donor, good outcome, change of practice and future directions.
    Poudyal BS; Shrestha GS; Tuladhar S; Gyawali B; Sedain G; Battajo R; Maskey P; Paudyal S; Regmi S; Rc DR; Kouides P
    Haemophilia; 2016 Sep; 22(5):e453-5. PubMed ID: 27353411
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of hemophilia B with a new clotting-factor concentrate.
    Hoag MS; Johnson FF; Robinson JA; Aggeler PM
    N Engl J Med; 1969 Mar; 280(11):581-6. PubMed ID: 5764825
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and efficacy of plasma-derived coagulation factor IX concentrate (AlphaNine® SD) in patients with haemophilia B undergoing surgical intervention: a single institution retrospective analysis.
    Quon DV; Logan L
    Haemophilia; 2011 Jan; 17(1):e196-201. PubMed ID: 20618876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of a patient with factor IX deficiency (hemophilia B) with coronary bypass surgery.
    Scharfman WB; Rauch AE; Ferraris V; Burkart PT
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):765-6. PubMed ID: 8469013
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of immune tolerance in hemophiliacs with inhibitors by combined treatment with i.v. IgG, cyclophosphamide and factor VIII or IX.
    Nilsson IM; Berntorp E
    Prog Clin Biol Res; 1990; 324():69-78. PubMed ID: 2106694
    [No Abstract]   [Full Text] [Related]  

  • 9. An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies.
    Mauser-Bunschoten EP; Kleine Budde I; Lopaciuk S; Koopman MM; Van Der Meer FJ; Novàkovà IR; Ypma P; Van Der Linden PW; Windyga J; Strengers PF
    Haemophilia; 2011 May; 17(3):439-45. PubMed ID: 21362109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey.
    Zappa S; McDaniel M; Marandola J; Allen G
    Haemophilia; 2012 May; 18(3):e140-53. PubMed ID: 22533455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine in previously treated patients with severe haemophilia B.
    Serban M; Skotnicki AB; Colovic M; Jinca C; Klukowska A; Laguna P; Wolf DM
    Haemophilia; 2012 Mar; 18(2):175-81. PubMed ID: 21812863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical operation in hemophilia B. Use of factor IX concentrate.
    Kasper CK
    Calif Med; 1970 Jul; 113(1):4-8. PubMed ID: 5520728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of F.IX-inhibitor bypassing activity contained in a commercial prothrombin complex concentrate (Proplex)].
    Sugimoto M; Fujimura Y; Okubo Y; Takahashi Y; Yoshioka A; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1984 Aug; 47(5):1181-9. PubMed ID: 6516702
    [No Abstract]   [Full Text] [Related]  

  • 14. [Substitution therapy of hemorrhagic diseases].
    Haupt H
    Anasthesiol Intensivmed Prax; 1975 Oct; 11(1):137-44. PubMed ID: 1225069
    [No Abstract]   [Full Text] [Related]  

  • 15. [Non-activated and activated prothrombin complex concentrates, Proplex and Feiba, in the treatment of a hemophilia B patient with high titer inhibitor against factor IX].
    Niiya K; Hirose S; Taguchi H; Miyoshi I
    Rinsho Ketsueki; 1985 Jun; 26(6):980-4. PubMed ID: 3877825
    [No Abstract]   [Full Text] [Related]  

  • 16. [SGPT increase in hemophilia patients during treatment with blood coagulation factor preparations].
    Kunst VA; Geerdink P
    Ned Tijdschr Geneeskd; 1979 Sep; 123(35):1513-9. PubMed ID: 492366
    [No Abstract]   [Full Text] [Related]  

  • 17. Focusing on haemophilia B: prophylaxis in Spanish patients.
    Aznar JA; Lucia JF; Abad-Franch L; Rubio R; Jimenez-Yuste V; Perez R; Batlle J; Balda I; Muñoz-Robles J; Parra R;
    Haemophilia; 2011 May; 17(3):542-3. PubMed ID: 21070494
    [No Abstract]   [Full Text] [Related]  

  • 18. Perioperative factor IX replacement for surgical resection of a suprasellar astrocytoma in a child with severe haemophilia B.
    Walker JA; Dixon N; Gururangan S; Thornburg C
    Haemophilia; 2008 Mar; 14(2):387-9. PubMed ID: 18194312
    [No Abstract]   [Full Text] [Related]  

  • 19. A clinical study assessing the pharmacokinetics, efficacy and safety of AlphaNine(®) , a high-purity factor IX concentrate, in patients with severe haemophilia B.
    Lissitchkov T; Matysiak M; Zavilska K; Laguna P; Gercheva L; Antonov A; Cabrera N; Aznar JA; Woodward MK; Páez A
    Haemophilia; 2011 Jul; 17(4):590-6. PubMed ID: 21299747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grifols' factor IX concentrates: new findings in biochemical characteristics and safety profiles.
    Herring S
    Haemophilia; 2010 Jul; 16 Suppl 6():3-8. PubMed ID: 20561351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.